Crinetics Pharmaceuticals, Inc. (CRNX): 25-NSE filed Sep 1, 2026

Form type

25-NSE

Filing date

Sep 1, 2026

Accession number

0001354457-26-000839

Filer

Crinetics Pharmaceuticals, Inc. (CIK 1658247)